Cargando…

High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years

Background: Recent studies investigating the use of optical coherence tomography (OCT) in multiple sclerosis (MS) patients have resulted in wide-ranging and often contradictory outcomes. This is mainly due to the complex etiology and heterogeneity of MS, physiological variations in the retinal nerve...

Descripción completa

Detalles Bibliográficos
Autores principales: Serbecic, Nermin, Aboul-Enein, Fahmy, Beutelspacher, Sven C., Khan, Adnan, Vass, Clemens, Kristoferitsch, Wolfgang, Reitner, Andreas, Schmidt-Erfurth, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932446/
https://www.ncbi.nlm.nih.gov/pubmed/24605107
http://dx.doi.org/10.3389/fneur.2014.00020
_version_ 1782304797595009024
author Serbecic, Nermin
Aboul-Enein, Fahmy
Beutelspacher, Sven C.
Khan, Adnan
Vass, Clemens
Kristoferitsch, Wolfgang
Reitner, Andreas
Schmidt-Erfurth, Ursula
author_facet Serbecic, Nermin
Aboul-Enein, Fahmy
Beutelspacher, Sven C.
Khan, Adnan
Vass, Clemens
Kristoferitsch, Wolfgang
Reitner, Andreas
Schmidt-Erfurth, Ursula
author_sort Serbecic, Nermin
collection PubMed
description Background: Recent studies investigating the use of optical coherence tomography (OCT) in multiple sclerosis (MS) patients have resulted in wide-ranging and often contradictory outcomes. This is mainly due to the complex etiology and heterogeneity of MS, physiological variations in the retinal nerve fiber layer (RNFL) and/or total macular volume (TMV), and limitations in methodology. It remains to be discovered whether any retinal changes in MS develop continuously or in a stepwise fashion, and whether these changes occur in all or a subset of patients. High-resolution spectral domain-OCT devices (SD-OCT) would be required to detect subtle retinal changes and longitudinal studies would have to be carried out to investigate retinal changes over time. In addition, if the hypothesis is correct, then retinal and global brain tissue changes should be detected in a substantial majority of MS patients and detection should be possible with a high degree of disease activity and/or long disease course. Methodology: In order to address the factors above, 37 MS patients (relapsing–remitting, n = 27; secondary progressive, n = 10) were examined prospectively on two occasions with a median interval of 22.4 ± 0.5 months [range 19–27]. SD-OCT was utilized with the Spectralis 3.5 mm circle scan protocol (with locked reference images and eye-tracking mode). None of the patients had optic neuritis 12 months prior to study entry or during the observation period. Principal Findings: The initial TMV pattern differed between study participants, but remained relatively unchanged over the 2-year observation period despite high disease activity or long disease course. The TMV correlated well with the RNFL. Conclusion: The significance of differences in TMV (and RNFL) between study participants remains unclear. Until these differences have been explored further, OCT data in MS patients should be interpreted with caution.
format Online
Article
Text
id pubmed-3932446
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-39324462014-03-06 High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years Serbecic, Nermin Aboul-Enein, Fahmy Beutelspacher, Sven C. Khan, Adnan Vass, Clemens Kristoferitsch, Wolfgang Reitner, Andreas Schmidt-Erfurth, Ursula Front Neurol Neuroscience Background: Recent studies investigating the use of optical coherence tomography (OCT) in multiple sclerosis (MS) patients have resulted in wide-ranging and often contradictory outcomes. This is mainly due to the complex etiology and heterogeneity of MS, physiological variations in the retinal nerve fiber layer (RNFL) and/or total macular volume (TMV), and limitations in methodology. It remains to be discovered whether any retinal changes in MS develop continuously or in a stepwise fashion, and whether these changes occur in all or a subset of patients. High-resolution spectral domain-OCT devices (SD-OCT) would be required to detect subtle retinal changes and longitudinal studies would have to be carried out to investigate retinal changes over time. In addition, if the hypothesis is correct, then retinal and global brain tissue changes should be detected in a substantial majority of MS patients and detection should be possible with a high degree of disease activity and/or long disease course. Methodology: In order to address the factors above, 37 MS patients (relapsing–remitting, n = 27; secondary progressive, n = 10) were examined prospectively on two occasions with a median interval of 22.4 ± 0.5 months [range 19–27]. SD-OCT was utilized with the Spectralis 3.5 mm circle scan protocol (with locked reference images and eye-tracking mode). None of the patients had optic neuritis 12 months prior to study entry or during the observation period. Principal Findings: The initial TMV pattern differed between study participants, but remained relatively unchanged over the 2-year observation period despite high disease activity or long disease course. The TMV correlated well with the RNFL. Conclusion: The significance of differences in TMV (and RNFL) between study participants remains unclear. Until these differences have been explored further, OCT data in MS patients should be interpreted with caution. Frontiers Media S.A. 2014-02-24 /pmc/articles/PMC3932446/ /pubmed/24605107 http://dx.doi.org/10.3389/fneur.2014.00020 Text en Copyright © 2014 Serbecic, Aboul-Enein, Beutelspacher, Khan, Vass, Kristoferitsch, Reitner and Schmidt-Erfurth. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Serbecic, Nermin
Aboul-Enein, Fahmy
Beutelspacher, Sven C.
Khan, Adnan
Vass, Clemens
Kristoferitsch, Wolfgang
Reitner, Andreas
Schmidt-Erfurth, Ursula
High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years
title High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years
title_full High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years
title_fullStr High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years
title_full_unstemmed High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years
title_short High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years
title_sort high-resolution spectral domain-optical coherence tomography in multiple sclerosis, part ii – the total macular volume. the first follow-up study over 2 years
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932446/
https://www.ncbi.nlm.nih.gov/pubmed/24605107
http://dx.doi.org/10.3389/fneur.2014.00020
work_keys_str_mv AT serbecicnermin highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years
AT abouleneinfahmy highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years
AT beutelspachersvenc highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years
AT khanadnan highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years
AT vassclemens highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years
AT kristoferitschwolfgang highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years
AT reitnerandreas highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years
AT schmidterfurthursula highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years